Based on earlier observations that CD133-positive cells exhibit resistance to chemotherapy, we investigated sensitivities to various anticancer drugs in monolayer cultured HCC using the high content screening (HCS) system. The gene discussed is PROM1; the disease is hepatocellular carcinoma.